Women's Health Market Research Reports & Industry Analysis
Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.
Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.
Women's Health Industry Research & Market Reports
-
Vaginal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Vaginal Cancer (Oncology) pipeline landscape. Vaginal cancer is a rare cancer that occurs in vagina. Symptoms includes watery vaginal discharge, a lump or mass in vagina, painful urination, constipation and ... Read More
-
Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Endometrial Cancer (Oncology) pipeline landscape. Endometrial cancer is cancer that starts in the endometrium, the lining of the uterus (womb). Endometrial cancer is the most common type of uterine cancer. ... Read More
-
Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Cervical Cancer (Oncology) pipeline landscape. Cervical cancer occurs when abnormal cells on the cervix grow out of control. Most cervical cancer is caused by a virus called human papillomavirus, or ... Read More
-
Breast Imaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... by 2027, registering a CAGR of 8.4% over the forecast period of the study, 2022 to 2027. The ongoing outbreak of COVID-19 showed an impact on the breast imaging market because hospital and healthcare services ... Read More
-
Polycystic Ovarian Syndrome Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 2022-2027. The outbreak of COVID-19 had a significant impact on the healthcare industry. The polycystic ovarian syndrome (PCOS) treatment market is not immune to the effects of the pandemic, which had ramifications for many surgical ... Read More
-
HER-2 Negative Breast Cancer Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 20.442.3 million by 2027, registering a CAGR of 10.08% over the forecast period. The emergence of the COVID-19 pandemic had an adverse effect on the world economy and healthcare system. The lockdown all over the ... Read More
-
Pregnancy Medication Market Size By Drug Class (Antianemia, Antacids, Antiallergic, Analgesics, Antimicrobials, Hormones, Laxatives, Vaccines, Nutritional Supplements {Minerals, Omega 3, Folic Acid, Vitamins, Multivitamins}), By Pregnancy Stage (1st Trimester, 2nd Trimester, 3rd Trimester), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 Global Pregnancy Medication Market is set to witness lucrative growth and record a ... Read More
-
Exploring Paths to Growth in Menstrual Care Amid Value Reckoning
... outstanding balance. However, these results have been skewed by the fact that the country’s chronically high inflation has been further exacerbated by the fallout of the global recovery from the pandemic and Russia’s invasion of ... Read More
-
Global Uterine Fibroids Treatment Market - 2022-2029
... over the forecast period 2022 to 2029. Uterine fibroids are a woman's uterus's most commonly benign, non-cancerous tumors, often seen during childbearing. Fibroids are only treated if they cause symptoms, and treatment options range from ... Read More
-
Global Endometriosis Drug Market - 2022-2029
... 10.4% in the forecasted period 2022-2029. Endometriosis is a painful ailment in which tissue analogous to the tissue that usually lines the inside of the uterus (endometrium) grows outside the uterus. Endometriosis most commonly involves ... Read More
-
Global Hormone Replacement Therapy (HRT) Market - 2022-2029
... a CAGR of 5.1% during the forecast period (2022-2029). Hormone replacement therapy (HRT) is a technique for replacing and replenishing hormones in the human body, which are at inadequate levels than those required for the ... Read More
-
Global Female Urinary Incontinence Treatment Device Market - 2022-2029
... growing at a CAGR of YY % during the forecast period (2022-2029). Female urinary incontinence has been diagnosed as a condition that causes involuntary urination. Urinary incontinence or stress urinary incontinence typically occurs during physical ... Read More
-
Global Cervical Cancer Treatment Market - 2022-2029
... cervix is the lower part of the uterus that connects to the vagina. Cervical cancer begins in the cells of the cervix. Most cervical malignancies are caused by strains of the sexually transmitted pathogen, Human ... Read More
-
Global Fertility Supplements Market - 2022-2029
... the forecast period 2022 to 2029. Fertility assists in producing offspring; however, in certain cases, failure in this process leads to infertility. To overcome such issues, there has been developed by pharmaceutical companies with the ... Read More
-
Global Premenstrual Syndrome Treatment Market - 2022-2029
... of 4.1% during the forecast period (2022-2029). Premenstrual Syndrome is a combination of physical and emotional symptoms, including mood swings, body pain, fatigue, tender breasts, food cravings, fatigue, irritability, and depression. It arises around the ... Read More
-
Global Ovulation Disorder Diagnosis Market - 2022-2029
... CAGR of 5.8% during the forecast period (2022-2029). Ovulation disorders are the main source of infertility in women or girls. Ovulation disorders are disturbances in the production of an egg during a woman’s menstrual cycle. ... Read More
-
Breast Cancer Drugs Market Size, Share & Trends Report, 2022-2030
... can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Breast Cancer Drugs market size will reach USD million ... Read More
-
Gynaecological devices Market Forecasts to 2028 – Global Analysis By Product (Gynecological endoscopy devices, Endometrial Ablation devices, Fluid management systems, Female Sterilization/ Contraceptive devices, Handheld instruments, Diagnostic imaging systems), End-user (Hospitals & Clinics, Ambulatory Surgery Centers) and Geography
... Centers) and Geography According to Stratistics MRC, the Global Ethylene Copolymer Market is accounted for $49.29 billion in 2022 and is expected to reach $69.91 billion by 2028 growing at a CAGR of 6.0% during ... Read More
-
Global Anti-Adhesion Products Market Insights, Forecast to 2028
... in 2022 and is forecast to a readjusted size of US$ 1139 million by 2028 with a CAGR of 7.36% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Film ... Read More
-
Vaginal Specula/Vaginal Speculum- Market Insights, Competitive Landscape and Market Forecast–2027
... (Diagnosis And Surgery), By End-User (Hospitals, Surgery Centers, Ambulatory Centres, Clinics, And Others), and by geography is expected to grow at a steady CAGR forecast till 2027 owing to rising incidence of cervical cancer and ... Read More
-
Uterine Cancer Therapeutics & Diagnostics
... at US$18.4 Billion in the year 2020, is projected to reach a revised size of US$24.3 Billion by 2027, growing at aCAGR of 4.1% over the period 2020-2027. Endometrial Carcinomas, one of the segments analyzed ... Read More
-
Polycystic ovarian syndrome - Pipeline Insight, 2022
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Women's Health Diagnostics
... 2020, is projected to reach a revised size of US$35.9 Billion by 2027, growing at a CAGR of 5.7% over the analysis period 2020-2027. Breast Cancer Testing, one of the segments analyzed in the report, ... Read More
-
Ovarian Cancer Market Share, Size, Trends, Industry Analysis Report, By Type (Epithelial Tumors, Germ Cell Tumors, Stromal Tumors, and Primary Peritoneal Cancer); By Diagnosis; By Therapeutic Treatment; By End-User; By Region; Segment Forecast, 2022 - 203
... 2030 The global ovarian cancer market is expected to reach USD 9.67 billion by 2030, according to a new study by Polaris Market Research. The report “Ovarian Cancer Market Share, Size, Trends, Industry Analysis Report, ... Read More
-
Polycystic ovarian syndrome - Pipeline Insight, 2022
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More